Core Viewpoint - The company, Saily Medical, is actively engaging in the brain-computer interface industry, having developed a digital management software for mental health conditions, which aligns with national policies promoting this sector [1] Group 1: Product Development - Saily Medical has established a digital therapy system named "Haisi Lingxi" targeting major mental illnesses such as depression and bipolar disorder, leveraging AI and internet technologies [1] - The software serves as a tool for researchers, doctors, and patients, creating a knowledge graph for brain science and related research [1] Group 2: Strategic Collaborations - In April 2024, Saily Medical will collaborate with Zhejiang University First Affiliated Hospital's Mental Health Center on a national key project focusing on common mental disorders [1] - A strategic cooperation framework was signed in early 2025 with Huawei Technologies and a key laboratory team to explore the application of brain science models in psychiatry [1] Group 3: Infrastructure and Technology - The company has established an AI diagnostic technology research center (TAIDxLab) in Shanghai, focusing on rapid molecular diagnostics and digital therapies for brain science [1] - The center utilizes Huawei's AI infrastructure to efficiently process large volumes of data and aims to create a secure ecosystem involving medical institutions, pharmaceutical companies, and regulatory bodies [1]

Core Viewpoint - The company, Saily Medical (603716.SH), is actively investing in the field of digital therapies for brain science, focusing on mental health management through innovative technology and strategic partnerships [1] Group 1: Company Initiatives - In 2022, Saily Medical began its strategic layout in the digital therapy sector for brain science, leveraging its subsidiary, Haisitai Medical Technology Co., Ltd., to develop a comprehensive digital management system for mental illnesses [1] - The "Haisilingxi" system, developed in collaboration with Zhejiang University First Affiliated Hospital's Mental Health Center, targets major mental disorders such as depression and bipolar disorder [1] - A national key project under the "Brain Plan 2030" was initiated in April 2024, involving multi-center studies across 14 leading medical institutions [1] Group 2: Strategic Partnerships - In early 2025, Saily Medical signed a strategic cooperation framework with Huawei Technologies and Professor Hu Shaohua's team from the National Key Laboratory of Brain-Machine Intelligence to explore the application of brain science models in psychiatry [1] - The collaboration aims to transition the industry from experience-driven to data-driven approaches, utilizing Huawei's computational infrastructure and clinical data [1] Group 3: Technological Development - By April 2025, Saily Medical established an AI diagnostic technology research center (TAIDx Lab) in Shanghai, focusing on rapid molecular diagnostics for infections and critical conditions, as well as digital therapies for brain science [1] - The lab is equipped with Huawei's Ascend AI cluster and Kunpeng servers to efficiently process large volumes of data, creating a secure and closed-loop system involving medical institutions, pharmaceutical companies, and regulatory bodies [1] - Future efforts will concentrate on advancing technology development and application to build core competitive advantages through technological barriers [1]